This site uses cookies, including third-party cookies, that help us to provide and improve our services.

Privacy Policy
- Global Locations -
Headquarters
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive, Suite 401, Newark, Delaware - 19713, United States
T: +1-845-579-5705
MEA
Market Access DMCC
1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Americas
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
Europe
Future Market Insights
3rd Floor, 207 Regent Street,
London W1B 3HH
United Kingdom
T: + 44 (0) 20 8123 9659
D: +44 (0) 20 3287 4268
APAC
Future Market Insights
Office No. 401-A, 4th Floor,
VANTAGE 9, S.No. 36/1/1,
Baner, Pune 411045 India

Digital Therapeutics Market

Market Insights on Digital Therapeutics covering sales outlook, demand forecast & up-to-date key trends

Digital Therapeutics Market by Solution, Application, Indication, Business Model & Region - Forecast 2022 – 2032

Digital Therapeutics Market Outlook (2022-2032)

[300 Pages Report] The global digital therapeutics market is set to reach a valuation of US$ 4.8 Bn in 2022. Expanding at an impressive 24.4% CAGR over the forecast period, total sales in the digital therapeutics market will reach US$ 42.5 Bn by 2032.

Data Points

Market Insights

Digital Therapeutics Market Value (2021)

US$ 3.9 Bn

Estimated Market Value (2022)

US$ 4.8 Bn

Projected Market Size (2032)

US$ 42.5 Bn

Value-based CAGR (2022-2032)

24.4%

Market Share of Top 5 Countries

44.4%

Digital therapies are software solutions used in the treatment of medical disorders, and they are a new trend emerging from the rapidly progressing mobile health market. These products are similar to consumer wellness applications in which they allow consumers to have more control over their care, but with one major difference: digital therapies are focused on providing enhanced clinical outcomes.

Digital treatments can provide aid to patients at many stages of their health care journey, in addition to addressing specific medical disorders. Through the process, digital treatment (DTx) gather, synthesizes, and analyse patient data so clinical professionals can fabricate treatment options and work with the patient to wean off complications. Better outcomes and fewer medical interventions are the end results.

Customize this Report

Let us know your requirement to get
100% FREE customization

2017-2021 Digital Therapeutics Market Historic Outlook Vs Forecast for 2022-2032

The digital therapeutics market grew at a CAGR of 22.0% between 2017 and 2021. The market value for global digital therapeutics held nearly 2.7% of the overall US$ 146 Bn digital health market in 2021.

The power of mobile technology to capture and hold people's attention is well known. A rising number of start-ups and established technology players are betting on that power to help people enhance their health outcomes in measurable ways.

These companies are driving software and health-care convergence in ways that can potentially change how the conventional approach of the life sciences industry, which involves both large pharma companies and medical technology or medical device companies, supports the patient health-care journey from beginning to end, spawning a new branch of medicine known as digital therapeutics.

Conventional therapies and treatments are still unable to meet unmet patient demand, while digital medicines offer the potential to do so. Enterprises that use digital therapies to close these gaps, together with substantially shorter product development timetables, may have a considerable edge over traditional life sciences companies.

Rising prevalence of preventable chronic diseases, the pressing need to regulate the cost of health care, a need for safe and accessible workarounds for the treatment of chronic and mental health diseases, a growing focus on predictive, preventative, personalised, and participatory healthcare, increasing investments in digital therapeutics are driving growth in the digital therapeutics market.

Digital therapeutics provide patient-oriented solutions through aspects such as digital behavioural interventions to devise evidence-based solutions on patient data, artificial intelligence and machine learning interventions, mobile health applications, gamification, and virtual reality. Driven by this, the market is expected to grow at a 24.4% CAGR and offer an absolute $ opportunity of nearly US$ 1 Bn between 2023 and 2022.

Digital Therapeutics Market Download Report Brochure

What are the Key Opportunities Propelling the Demand for Digital Therapeutics?

Numerous start-ups and existing technology companies are banking on the ability of mobile technology to help people improve their health in quantifiable ways. Manufacturers are driving software and healthcare convergence in ways that are expected to change the life sciences industry's traditional approach, which includes both large pharma and medical technology or medical device companies, supports the patient's medical journey. This has spawned a new branch of medicine known as digital therapeutics and will provide lucrative opportunities for growth over the forecast period.

Furthermore, digital therapeutics provide pharmaceutical and MedTech businesses with a low-cost approach to differentiate products, especially when compared to the research and development costs generally involved with traditional medicine or medical device.

Many businesses are refocusing their R&D efforts away from core product lines and toward revolutionary innovation. Digital medicines also have the potential to lengthen product life cycles, differentiate in-development goods, and cover market gaps that traditional medicine may not be able to fill. All these factors are expected to augment the growth in the market over the assessment period.  

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

What Factors are Limiting Sales in the Digital Therapeutics Market?

Wearable healthcare faces several challenges, including the fact that the data provided cannot always be used to track, diagnose, and treat health disorders due to ongoing concerns about data accuracy, consistency, and privacy.

Additionally, stakeholder awareness, acceptance, and engagement are issues for many firms that have joined the DTx industry. Most DTx solutions have entered the market with product-centric revenue models and go-to-market strategies to date.

 Instead of satisfying unmet requirements of patients and other essential stakeholders across the end-to-end continuum of care, their focus has been on selling more products. As a result, the market for isolated digital point solutions is fragmented, confused, and overcrowded. There is no genuinely comprehensive, patient-centric experience to assist patients in navigating the present complex healthcare system.

As a result of the additional time and money spent on product development, the marketing and commercial sales teams are underp ressure to produce successful go-to-market plans for DTx launch, scale-up, and growth. These factors, together, induce a restrictive impact upon the growth of the overall digital therapeutics market.

Country-wise Insights

What Makes the U.S. the Largest Market for Digital Therapeutics?

“Rapid Adoption of Connective Technology-Based Medical Equipment Will Fuel Sales of Digital Therapeutics”

The U.S. dominated the North America digital therapeutics market in 2021, holding about 90.3% of the market share. As per FMI, the trend is projected to continue over the forecast period. Growth is associated with the high burden of chronic disease in the general population within the country.

Increasing incidence of gastrointestinal and central nervous system diseases is underpinning the demand for digital therapeutics. With growing adoption of telemedicine, integration and adoption of mobile health analytics in the U.S., sales are expected to increase over the forecast period.

Why is China Considered a Lucrative Market for Digital Therapeutics?

“Growing Demand for Digital Therapeutics for Insomnia Will Augment Growth”

China is expected to account for 48.0% of the East Asia digital therapeutics market share in 2022. After the third wave of automation and digital technology integration propelled by the advent of the COVID-19 pandemic, China has established full automation solutions for medical and production facilities.

The local government has joined forces with leading DTx organisations with a joint commitment of 20 billion RMB ($32 billion) in funding support to formalise a massive DTx Industrial Park project, which is a promising indicator of Chinese DTx market progress. The project's details and funding proposal have yet to be revealed, but a newly built DTx Industrial Park in Zhejiang Province will soon serve as the DTx industrial flagship in China.

What is Driving the Germany Digital Therapeutics Market?

“Rising Awareness Regarding Digital Therapeutics Technology Will Boost Sales in Germany”

With a high volume of the disease burden associated with chronic ailments such as cardiovascular diseases, diabetes, and cancer, demand for digital therapeutics in Germany is anticipated to remain high. As per the report, the Germany digital therapeutics market will expand at a 20.6% CAGR over the forecast period.  

In 2019, the German Parliament passed the Digital Healthcare Act (DigitaleVersorgung-Gesetz, or DVG), allowing all German doctors to prescribe digital treatments to publicly-insured patients in Germany. This has enhanced the accessibility of safe digital solutions for the treatment of chronic and mental health diseases.

Become a MarketNgage Insider

An unified Market Research Subscription Platform, built for today’s disparate research needs.

Category-wise Insights

Which Digital Therapeutics Solution is Widely Adopted?

“Demand for Combination Therapy Will Gain Traction”

Based on solution, the combination therapy segment is projected to account for 68.4% of the total market share in 2022. Combination therapy with biopharmaceuticals, or “smart drugs” offers an exciting way to improve patient adherence and outcomes. Pharmaceutical companies can assist patients in improving their health outcomes by digitising drugs and utilising digital interventions to encourage their proper usage.

Which Applications of Digital Therapeutics are Driving the Market?

“Adoption of Digital Therapeutics for Disease Prevention Will Rise”

In terms of applications, the prevention segment is forecast to hold 35.8% of the total market share in 2022. For patients at risk of developing more serious ailments, digital therapeutics are routinely used as a prophylactic measure. These prevention measures provide approaches and solutions that could delay the onset of the chronic disease.

Which Indication is More in Focus in the Digital Therapeutics Market?

“Sales of Digital Therapeutics for Central Nervous Systems Disorders Will Boost Demand”

By indication, sales in the central nervous system disorders segment will increase at a CAGR of 29.2% over the assessment period. Several drugs that are now in use were discovered as a result of drug discovery research intended to treat central nervous system (CNS) illnesses.

However, not all drugs can relieve patients of the symptoms of their disorders, and CNS dysfunction is still a medical area with many unmet needs. Medical solutions which utilize digital technologies can address these unmet needs.

Which Business Model is Most Preferred For Digital Therapeutics?

“Sales of Digital Therapeutics Direct to Patients Will Gain Momentum”

Based on distribution channel, the direct-to-patients/consumers segment will hold about 60.1% of the total market share over the forecast period. With the products being sold directly to the consumer, the availability of mobile health solutions provide customers with solutions linked to enhanced patient compliance and better clinical outcomes.

Competitive Landscape

The market for digital therapeutics is a fragmented. With the emergence of start-ups and other market players, the global market is likely to witness the heavy competition. Companies are aiming to launch digital health campaigns and software solutions for a comprehensive patient care regimen. For instance:

  • Teladoc Health in February 2022 launched the “Chronic Care Complete” management solution aimed at improving health outcomes for patients living with chronic conditions.
  • • In September 2020, Boehringer Ingelheim and Click Therapeutics agreed to collaborate on the development and commercialization of CT-155, a novel prescription digital therapy for schizophrenia.

Report Scope as per Digital Therapeutics Industry Analysis

Attribute

Details

Forecast Period

2022-2032

Historical Data Available for

2017-2021

Market Analysis

US$ Bn for Value

Key Regions Covered

North America, Latin America, Europe, South Asia, East Asia, Oceania, Middle East and Africa (MEA)

Key Countries Covered

 

The U.S., Canada, Brazil, Mexico, Argentina, Germany, Italy, France, Spain, the U.K., Russia, BENELUX, China, Japan, South Korea, India, Indonesia, Thailand, Malaysia, Australia, New Zealand, GCC Countries and Turkey

Key Companies Covered

  • Teladoc Health, Inc.
  • Click Therapeutics, Inc.
  • Welldoc
  • HYGIEIA
  • DarioHealth Corp
  • BigHealth
  • Orexo AB
  • Akili Interactive Labs, Inc.
  • Freespira
  • Voluntis
  • Kaia Health
  • Kaiku Health
  • Theranica Bio-Electronics Ltd.
  • Propeller Health
  • Orexo US, Inc.
  • TALi Digital Limited
  • Limbix Health, Inc.

Key Market Segments Covered

Solution, Application, Indication, Business Model and Region

Key Market Segments Covered in Digital Therapeutics Industry Research

By Solution:

  • Monotherapy
  • Combination Therapy

By Application:

  • Prevention
  • Management
  • Treatment

By Indication:

  • Diabetes
  • Obesity
  • Gastrointestinal Disorders
  • Cardiovascular Disease
  • Central Nervous Systems
  • Others

By Business Model:

  • Direct to consumer
  • Fee-for-service

By Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East & Africa (MEA)

Frequently Asked Questions

The global digital therapeutics market is worth US$ 4.8 Bn in 2022 and is set to expand 8.9X over the next ten years.

The global digital therapeutics market is expected to reach US$ 42.5 Bn by the end of 2032, with sales revenue expected to register a 24.4% CAGR.

Some of the significant trends in this market are the reimagined regulatory pathway for software as a medical device (SaMD) products, the rising adoption of medical technology, and the global prevalence of chronic and mental diseases.

Canada, the U.S., France, the U.K., and Italy are expected to drive demand for global digital therapeutics products.

The U.S. is one of the key markets for global digital therapeutics, accounting for about 86.2% of the overall North American market during the forecast period.

The U.S., Germany and Canada are the key producers in the global digital therapeutics market space.

Table of Content

1. Executive Summary

    1.1. Global Market Outlook

    1.2. Demand Side Trends

    1.3. Supply Side Trends

    1.4. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

    2.3. Inclusions and Exclusions

3. Key Market Trends

    3.1. Key Trends Impacting the Market

    3.2. Product Innovation / Development Trends

4. Key Success Factors

    4.1. Key Strategies, By Key Players

    4.2. Regulatory Landscape

    4.3. Reimbursement Scenario

    4.4. Collaboration between pharma & digital therapeutics providers 

    4.5. PESTEL Analysis

5. Market Background

    5.1. Macro-Economic Factors

        5.1.1. Global GDP Growth Outlook

        5.1.2. Global Healthcare Outlook

        5.1.3. Global Digital Health Market Outlook

    5.2. Forecast Factors - Relevance & Impact

        5.2.1. Rising prevalence of chronic  diseases

        5.2.2. Technological Advancements

        5.2.3. Rising adoption of telehealth

        5.2.4. Cost-effectiveness

        5.2.5. Supportive rules and regulations

        5.2.6. Rise in demand for digital therapeutics

        5.2.7. Strategic Mergers and Acquisitions

    5.3. Market Dynamics

        5.3.1. Drivers

        5.3.2. Restraints

        5.3.3. Opportunity Analysis

6. COVID19 Crisis Analysis

    6.1. COVID19 and Impact Analysis

        6.1.1. By Solution 

        6.1.2. By Application

        6.1.3. By Indication

        6.1.4. By Country

    6.2. 2021 Market Scenario

7. Global Digital Therapeutics Market Demand (in Value or Size in US$ Bn) Analysis 2017-2021 and Forecast, 2022–2032

    7.1. Historical Market Value (US$ Bn) Analysis, 2017-2021

    7.2. Current and Future Market Value (US$ Bn) Projections, 2022–2032

        7.2.1. Y-o-Y Growth Trend Analysis

        7.2.2. Absolute $ Opportunity Analysis

8. Global Digital Therapeutics Market Analysis 2017-2021 and Forecast 2022–2032, By Solution  

    8.1. Introduction / Key Findings

    8.2. Historical Market Size (US$ Bn) Analysis By Solution, 2017-2021

    8.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Solution, 2022–2032

        8.3.1. Monotherapy

        8.3.2. Combination Therapy

    8.4. Market Attractiveness Analysis By Solution  

9. Global Digital Therapeutics Market Analysis 2017-2021 and Forecast 2022–2032, By Application

    9.1. Introduction / Key Findings

    9.2. Historical Market Size (US$ Bn) Analysis, By Application, 2017-2021

    9.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Application, 2022–2032

        9.3.1. Prevention

        9.3.2. Management

        9.3.3. Treatment 

    9.4. Market Attractiveness Analysis By Application

10. Global Digital Therapeutics Market Analysis 2017-2021 and Forecast 2022–2032, By Indication 

    10.1. Introduction / Key Findings

    10.2. Historical Market Size (US$ Bn) Analysis, By Indication, 2017-2021

    10.3. Current and Future Market Size (US$ Bn) Analysis Forecast By Indication, 2022–2032

        10.3.1. Diabetes

        10.3.2. Obesity

        10.3.3. Gastrointestinal Disorders

        10.3.4. Cardiovascular Disease

        10.3.5. Central Nervous Systems

        10.3.6. Others

    10.4. Market Attractiveness Analysis By Indication

11. Global Digital Therapeutics Market Analysis 2017-2021 and Forecast 2022–2032, By Business Model 

    11.1. Introduction / Key Findings

    11.2. Historical Market Size (US$ Bn) Analysis, By  Business Model, 2017-2021

    11.3. Current and Future Market Size (US$ Bn) Analysis Forecast By Business Model, 2022–2032

        11.3.1. Direct to consumer

        11.3.2. Fee-for-service

    11.4. Market Attractiveness Analysis By Business Model

12. Global Digital Therapeutics Market Analysis 2017-2021 and Forecast 2022–2032, By Region

    12.1. Introduction

    12.2. Historical Market Size (US$ Bn) Analysis By Region, 2017-2021

    12.3. Current and Future Market Value (US$ Bn) Projections, 2022–2032

        12.3.1. North America

        12.3.2. Latin America

        12.3.3. Europe

        12.3.4. East Asia

        12.3.5. South Asia

        12.3.6. Oceania

        12.3.7. Middle East and Africa (MEA)

    12.4. Market Attractiveness Analysis By Region

13. North America Digital Therapeutics Market Analysis 2017-2021 and Forecast 2022–2032

    13.1. Introduction

    13.2. Historical Market Size (US$ Bn) Analysis Trend Analysis By Market Taxonomy, 2017-2021

    13.3. Current and Future Market Value (US$ Bn) Projections, 2022–2032

        13.3.1. By Country

            13.3.1.1. U.S.

            13.3.1.2. Canada

        13.3.2. By Solution 

        13.3.3. By Application

        13.3.4. By Indication

        13.3.5. By Business Model 

    13.4. Market Attractiveness Analysis

        13.4.1. By Country

        13.4.2. By Solution 

        13.4.3. By Application

        13.4.4. By Indication

        13.4.5. By Business Model

    13.5. Market Trends

    13.6. Key Market Participants - Intensity Mapping

    13.7. Drivers and Restraints - Impact Analysis

    13.8. Country Level Analysis & Forecast

        13.8.1. U.S. Digital Therapeutics Market Analysis

            13.8.1.1. Introduction

            13.8.1.2. Market Analysis and Forecast by Market Taxonomy

                13.8.1.2.1. By Solution 

                13.8.1.2.2. By Application

                13.8.1.2.3. By Indication

                13.8.1.2.4. By Business Model

        13.8.2. Canada Digital Therapeutics Market Analysis

            13.8.2.1. Introduction

            13.8.2.2. Market Analysis and Forecast by Market Taxonomy

                13.8.2.2.1. By Solution 

                13.8.2.2.2. By Application

                13.8.2.2.3. By Indication

                13.8.2.2.4. By Business Model

14. Latin America Digital Therapeutics Market Analysis 2017-2021 and Forecast 2022–2032

    14.1. Introduction

    14.2. Historical Market Size (US$ Bn) Analysis Trend Analysis By Market Taxonomy, 2017-2021

    14.3. Current and Future Market Value (US$ Bn) Projections, 2022–2032

        14.3.1. By Country

            14.3.1.1. Mexico

            14.3.1.2. Brazil

            14.3.1.3. Argentina

            14.3.1.4. Rest of Latin America

        14.3.2. By Solution 

        14.3.3. By Application

        14.3.4. By Indication

        14.3.5. By Business Model

    14.4. Market Attractiveness Analysis

        14.4.1. By Country

        14.4.2. By Solution 

        14.4.3. By Application

        14.4.4. By Indication

        14.4.5. By Business Model

    14.5. Market Trends

    14.6. Key Market Participants - Intensity Mapping

    14.7. Drivers and Restraints - Impact Analysis

    14.8. Country Level Analysis & Forecast

        14.8.1. Mexico Digital Therapeutics Market Analysis

            14.8.1.1. Introduction

            14.8.1.2. Market Analysis and Forecast by Market Taxonomy

                14.8.1.2.1. By Solution 

                14.8.1.2.2. By Application

                14.8.1.2.3. By Indication

                14.8.1.2.4. By Business Model

        14.8.2. Brazil Digital Therapeutics Market Analysis

            14.8.2.1. Introduction

            14.8.2.2. Market Analysis and Forecast by Market Taxonomy

                14.8.2.2.1. By Solution 

                14.8.2.2.2. By Application

                14.8.2.2.3. By Indication

                14.8.2.2.4. By Business Model

        14.8.3. Argentina Digital Therapeutics Market Analysis

            14.8.3.1. Introduction

            14.8.3.2. Market Analysis and Forecast by Market Taxonomy

                14.8.3.2.1. By Solution 

                14.8.3.2.2. By Application

                14.8.3.2.3. By Indication

                14.8.3.2.4. By Business Model

15. Europe Digital Therapeutics Market Analysis 2017-2021 and Forecast 2022–2032

    15.1. Introduction

    15.2. Historical Market Size (US$ Bn) Analysis Trend Analysis By Market Taxonomy, 2017-2021

    15.3. Current and Future Market Value (US$ Bn) Projections, 2022–2032

        15.3.1. By Country

            15.3.1.1. Germany

            15.3.1.2. Italy

            15.3.1.3. France

            15.3.1.4. U.K.

            15.3.1.5. Spain

            15.3.1.6. BENELUX

            15.3.1.7. Nordic Countries & Russia

            15.3.1.8. Rest of Europe

        15.3.2. By Solution 

        15.3.3. By Application

        15.3.4. By Indication

        15.3.5. By Business Model

    15.4. Market Attractiveness Analysis

        15.4.1. By Country

        15.4.2. By Solution 

        15.4.3. By Application

        15.4.4. By Indication

        15.4.5. By Business Model

    15.5. Market Trends

    15.6. Key Market Participants - Intensity Mapping

    15.7. Drivers and Restraints - Impact Analysis

    15.8. Country Level Analysis & Forecast

        15.8.1. Germany Digital Therapeutics Market Analysis

            15.8.1.1. Introduction

            15.8.1.2. Market Analysis and Forecast by Market Taxonomy

                15.8.1.2.1. By Solution 

                15.8.1.2.2. By Application

                15.8.1.2.3. By Indication

                15.8.1.2.4. By Business Model

        15.8.2. Italy Digital Therapeutics Market Analysis

            15.8.2.1. Introduction

            15.8.2.2. Market Analysis and Forecast by Market Taxonomy

                15.8.2.2.1. B By Solution 

                15.8.2.2.2. By Application

                15.8.2.2.3. By Indication

                15.8.2.2.4. By Business Model

        15.8.3. France Digital Therapeutics Market Analysis

            15.8.3.1. Introduction

            15.8.3.2. Market Analysis and Forecast by Market Taxonomy

                15.8.3.2.1. By Solution 

                15.8.3.2.2. By Application

                15.8.3.2.3. By Indication

                15.8.3.2.4. By Business Model

        15.8.4. U.K. Digital Therapeutics Market Analysis

            15.8.4.1. Introduction

            15.8.4.2. Market Analysis and Forecast by Market Taxonomy

                15.8.4.2.1. By Solution 

                15.8.4.2.2. By Application

                15.8.4.2.3. By Indication

                15.8.4.2.4. By Business Model

        15.8.5. Spain Digital Therapeutics Market Analysis

            15.8.5.1. Introduction

            15.8.5.2. Market Analysis and Forecast by Market Taxonomy

                15.8.5.2.1. By Solution 

                15.8.5.2.2. By Application

                15.8.5.2.3. By Indication

                15.8.5.2.4. By Business Model

        15.8.6. BENELUX Digital Therapeutics Market Analysis

            15.8.6.1. Introduction

            15.8.6.2. Market Analysis and Forecast by Market Taxonomy

                15.8.6.2.1. By Solution 

                15.8.6.2.2. By Application

                15.8.6.2.3. By Indication

                15.8.6.2.4. By Business Model

        15.8.7. Nordic Countries & Russia Digital Therapeutics Market Analysis

            15.8.7.1. Introduction

            15.8.7.2. Market Analysis and Forecast by Market Taxonomy

                15.8.7.2.1. By Solution 

                15.8.7.2.2. By Application

                15.8.7.2.3. By Indication

                15.8.7.2.4. By Business Model

16. East Asia Digital Therapeutics Market Analysis 2017-2021 and Forecast 2022–2032

    16.1. Introduction

    16.2. Historical Market Size (US$ Bn) Analysis Trend Analysis By Market Taxonomy, 2017-2021

    16.3. Current and Future Market Value (US$ Bn) Projections, 2022–2032

        16.3.1. By Country

            16.3.1.1. China

            16.3.1.2. Japan

            16.3.1.3. South Korea

        16.3.2. By Solution 

        16.3.3. By Application

        16.3.4. By Indication

        16.3.5. By Business Model

    16.4. Market Attractiveness Analysis

        16.4.1. By Country

        16.4.2. By Solution 

        16.4.3. By Application

        16.4.4. By Indication

        16.4.5. By Business Model

    16.5. Market Trends

    16.6. Key Market Participants - Intensity Mapping

    16.7. Drivers and Restraints - Impact Analysis

    16.8. Country Level Analysis & Forecast

        16.8.1. China Digital Therapeutics Market Analysis

            16.8.1.1. Introduction

            16.8.1.2. Market Analysis and Forecast by Market Taxonomy

                16.8.1.2.1. By Solution 

                16.8.1.2.2. By Application

                16.8.1.2.3. By Indication

                16.8.1.2.4. By Business Model

        16.8.2. Japan Digital Therapeutics Market Analysis

            16.8.2.1. Introduction

            16.8.2.2. Market Analysis and Forecast by Market Taxonomy

                16.8.2.2.1. By Solution 

                16.8.2.2.2. By Application

                16.8.2.2.3. By Indication

                16.8.2.2.4. By Business Model

        16.8.3. South Korea Digital Therapeutics Market Analysis

            16.8.3.1. Introduction

            16.8.3.2. Market Analysis and Forecast by Market Taxonomy

                16.8.3.2.1. By Solution 

                16.8.3.2.2. By Application

                16.8.3.2.3. By Indication

                16.8.3.2.4. By Business Model

17. South Asia Digital Therapeutics Market Analysis 2017-2021 and Forecast 2022–2032

    17.1. Introduction

    17.2. Historical Market Size (US$ Bn) Analysis Trend Analysis By Market Taxonomy, 2017-2021

    17.3. Current and Future Market Value (US$ Bn) Projections, 2022–2032

        17.3.1. By Country

            17.3.1.1. India

            17.3.1.2. Indonesia

            17.3.1.3. Malaysia

            17.3.1.4. Thailand

            17.3.1.5. Philippines

            17.3.1.6. Vietnam

            17.3.1.7. Rest of South Asia

        17.3.2. By Solution 

        17.3.3. By Application

        17.3.4. By Indication

        17.3.5. By Business Model

    17.4. Market Attractiveness Analysis

        17.4.1. By Country

        17.4.2. By Solution 

        17.4.3. By Application

        17.4.4. By Indication

        17.4.5. By Business Model

    17.5. Market Trends

    17.6. Key Market Participants - Intensity Mapping

    17.7. Drivers and Restraints - Impact Analysis

    17.8. Country Level Analysis & Forecast

        17.8.1. India Digital Therapeutics Market Analysis

            17.8.1.1. Introduction

            17.8.1.2. Market Analysis and Forecast by Market Taxonomy

                17.8.1.2.1. By Solution 

                17.8.1.2.2. By Application

                17.8.1.2.3. By Indication

                17.8.1.2.4. By Business Model

        17.8.2. Indonesia Digital Therapeutics Market Analysis

            17.8.2.1. Introduction

            17.8.2.2. Market Analysis and Forecast by Market Taxonomy

                17.8.2.2.1. By Solution 

                17.8.2.2.2. By Application

                17.8.2.2.3. By Indication

                17.8.2.2.4. By Business Model

        17.8.3. Malaysia Digital Therapeutics Market Analysis

            17.8.3.1. Introduction

            17.8.3.2. Market Analysis and Forecast by Market Taxonomy

                17.8.3.2.1. By Solution 

                17.8.3.2.2. By Application

                17.8.3.2.3. By Indication

                17.8.3.2.4. By Business Model

        17.8.4. Thailand Digital Therapeutics Market Analysis

            17.8.4.1. Introduction

            17.8.4.2. Market Analysis and Forecast by Market Taxonomy

                17.8.4.2.1. By Solution 

                17.8.4.2.2. By Application

                17.8.4.2.3. By Indication

                17.8.4.2.4. By Business Model

        17.8.5. Philippines Digital Therapeutics Market Analysis

            17.8.5.1. Introduction

            17.8.5.2. Market Analysis and Forecast by Market Taxonomy

                17.8.5.2.1. By Solution 

                17.8.5.2.2. By Application

                17.8.5.2.3. By Indication 

                17.8.5.2.4. By Business Model

        17.8.6. Vietnam Digital Therapeutics Market Analysis

            17.8.6.1. Introduction

            17.8.6.2. Market Analysis and Forecast by Market Taxonomy

                17.8.6.2.1. By Solution 

                17.8.6.2.2. By Application

                17.8.6.2.3. By Indication

                17.8.6.2.4. By Business Model

18. Oceania Digital Therapeutics Market 2017-2021 and Forecast 2022-2032

    18.1. Introduction

    18.2. Historical Market Size (US$ Bn) Analysis Trend Analysis By Market Taxonomy, 2017-2021

    18.3. Current and Future Market Value (US$ Bn) Projections, 2022–2032

        18.3.1. By Country

            18.3.1.1. Australia

            18.3.1.2. New Zealand

        18.3.2. By Solution 

        18.3.3. By Application

        18.3.4. By Indication

        18.3.5. By Business Model

    18.4. Market Attractiveness Analysis

        18.4.1. By Country

        18.4.2. By Solution 

        18.4.3. By Application

        18.4.4. By Indication

        18.4.5. By Business Model

    18.5. Key Market Participants - Intensity Mapping

    18.6. Drivers and Restraints - Impact Analysis

    18.7. Country Level Analysis & Forecast

        18.7.1. Australia Digital Therapeutics Market Analysis

            18.7.1.1. Introduction

            18.7.1.2. Market Analysis and Forecast by Market Taxonomy

                18.7.1.2.1. By Solution 

                18.7.1.2.2. By Application

                18.7.1.2.3. By Indication

                18.7.1.2.4. By Business Model

        18.7.2. New Zealand Digital Therapeutics Market Analysis

            18.7.2.1. Introduction

            18.7.2.2. Market Analysis and Forecast by Market Taxonomy

                18.7.2.2.1. By Solution 

                18.7.2.2.2. By Application

                18.7.2.2.3. By Indication

                18.7.2.2.4. By Business Model

19. Middle East and Africa (MEA) Digital Therapeutics Market Analysis 2017-2021 and Forecast 2022–2032

    19.1. Introduction

    19.2. Historical Market Size (US$ Bn) Analysis Trend Analysis By Market Taxonomy, 2017-2021

    19.3. Current and Future Market Value (US$ Bn) Projections, 2022–2032

        19.3.1. By Country

            19.3.1.1. GCC Countries

            19.3.1.2. Israel

            19.3.1.3. Turkey

            19.3.1.4. South Africa & North Africa

            19.3.1.5. Rest of Middle East and Africa

        19.3.2. By Solution 

        19.3.3. By Application

        19.3.4. By Indication

        19.3.5. By Business Model

    19.4. Market Attractiveness Analysis

        19.4.1. By Country

        19.4.2. By Solution 

        19.4.3. By Application

        19.4.4. By Indication

        19.4.5. By Business Model

    19.5. Market Trends

    19.6. Key Market Participants - Intensity Mapping

    19.7. Drivers and Restraints - Impact Analysis

    19.8. Country Level Analysis & Forecast

        19.8.1. GCC Countries Digital Therapeutics Market Analysis

            19.8.1.1. Introduction

            19.8.1.2. Market Analysis and Forecast by Market Taxonomy

                19.8.1.2.1. By Solution 

                19.8.1.2.2. By Application

                19.8.1.2.3. By Indication

                19.8.1.2.4. By Business Model

        19.8.2. Israel Digital Therapeutics Market Analysis

            19.8.2.1. Introduction

            19.8.2.2. Market Analysis and Forecast by Market Taxonomy

                19.8.2.2.1. By Solution 

                19.8.2.2.2. By Application

                19.8.2.2.3. By Indication

                19.8.2.2.4. By Business Model

        19.8.3. Turkey Digital Therapeutics Market Analysis

            19.8.3.1. Introduction

            19.8.3.2. Market Analysis and Forecast by Market Taxonomy

                19.8.3.2.1. By Solution 

                19.8.3.2.2. By Application

                19.8.3.2.3. By Indication

                19.8.3.2.4. By Business Model

        19.8.4. South Africa & North Africa Digital Therapeutics Market Analysis

            19.8.4.1. Introduction

            19.8.4.2. Market Analysis and Forecast by Market Taxonomy

                19.8.4.2.1. By Solution 

                19.8.4.2.2. By Application

                19.8.4.2.3. By Indication

                19.8.4.2.4. By Business Model

20. Market Structure Analysis

    20.1. Market Analysis by Tier of Companies

    20.2. Market Share Analysis of Top Players

    20.3. Market Presence Analysis

        20.3.1. By Regional Footprint of Players

        20.3.2. By Channel Footprint of Players

21. Competition Analysis

    21.1. Competition Dashboard

    21.2. Competition Benchmarking

    21.3. Competition Deep Dive 

        21.3.1. Teladoc Health, Inc.

            21.3.1.1. Overview

            21.3.1.2. Product Portfolio

            21.3.1.3. Key Financials

            21.3.1.4. Sales Footprint

            21.3.1.5. SWOT Analysis

            21.3.1.6. Strategy Overview

                21.3.1.6.1. Marketing Strategy

                21.3.1.6.2. Channel Strategy

        21.3.2. Click Therapeutics, Inc.

            21.3.2.1. Overview

            21.3.2.2. Product Portfolio

            21.3.2.3. Key Financials

            21.3.2.4. Sales Footprint

            21.3.2.5. SWOT Analysis

            21.3.2.6. Strategy Overview

                21.3.2.6.1. Marketing Strategy

                21.3.2.6.2. Channel Strategy

        21.3.3. Welldoc

            21.3.3.1. Overview

            21.3.3.2. Product Portfolio

            21.3.3.3. Key Financials

            21.3.3.4. Sales Footprint

            21.3.3.5. SWOT Analysis

            21.3.3.6. Strategy Overview

                21.3.3.6.1. Marketing Strategy

                21.3.3.6.2. Channel Strategy

        21.3.4. HYGIEIA 

            21.3.4.1. Overview

            21.3.4.2. Product Portfolio

            21.3.4.3. Key Financials

            21.3.4.4. Sales Footprint

            21.3.4.5. SWOT Analysis

            21.3.4.6. Strategy Overview

                21.3.4.6.1. Marketing Strategy

                21.3.4.6.2. Channel Strategy

        21.3.5. DarioHealth Corp

            21.3.5.1. Overview

            21.3.5.2. Product Portfolio

            21.3.5.3. Key Financials

            21.3.5.4. Sales Footprint

            21.3.5.5. SWOT Analysis

            21.3.5.6. Strategy Overview

                21.3.5.6.1. Marketing Strategy

                21.3.5.6.2. Channel Strategy

        21.3.6. BigHealth

            21.3.6.1. Overview

            21.3.6.2. Product Portfolio

            21.3.6.3. Key Financials

            21.3.6.4. Sales Footprint

            21.3.6.5. SWOT Analysis

            21.3.6.6. Strategy Overview

                21.3.6.6.1. Marketing Strategy

                21.3.6.6.2. Channel Strategy

        21.3.7. Orexo AB

            21.3.7.1. Overview

            21.3.7.2. Product Portfolio

            21.3.7.3. Key Financials

            21.3.7.4. Sales Footprint

            21.3.7.5. SWOT Analysis

            21.3.7.6. Strategy Overview

                21.3.7.6.1. Marketing Strategy

                21.3.7.6.2. Channel Strategy

        21.3.8. Akili Interactive Labs, Inc.

            21.3.8.1. Overview

            21.3.8.2. Product Portfolio

            21.3.8.3. Key Financials

            21.3.8.4. Sales Footprint

            21.3.8.5. SWOT Analysis

            21.3.8.6. Strategy Overview

                21.3.8.6.1. Marketing Strategy

                21.3.8.6.2. Channel Strategy

        21.3.9. Freespira

            21.3.9.1. Overview

            21.3.9.2. Product Portfolio

            21.3.9.3. Key Financials

            21.3.9.4. Sales Footprint

            21.3.9.5. SWOT Analysis

            21.3.9.6. Strategy Overview

                21.3.9.6.1. Marketing Strategy

                21.3.9.6.2. Channel Strategy

        21.3.10. Voluntis

            21.3.10.1. Overview

            21.3.10.2. Product Portfolio

            21.3.10.3. Key Financials

            21.3.10.4. Sales Footprint

            21.3.10.5. SWOT Analysis

            21.3.10.6. Strategy Overview

                21.3.10.6.1. Marketing Strategy

                21.3.10.6.2. Channel Strategy

        21.3.11. Kaia Health

            21.3.11.1. Overview

            21.3.11.2. Product Portfolio

            21.3.11.3. Key Financials

            21.3.11.4. Sales Footprint

            21.3.11.5. SWOT Analysis

            21.3.11.6. Strategy Overview

                21.3.11.6.1. Marketing Strategy

                21.3.11.6.2. Channel Strategy

        21.3.12. Kaiku Health

            21.3.12.1. Overview

            21.3.12.2. Product Portfolio

            21.3.12.3. Key Financials

            21.3.12.4. Sales Footprint

            21.3.12.5. SWOT Analysis

            21.3.12.6. Strategy Overview

                21.3.12.6.1. Marketing Strategy

                21.3.12.6.2. Channel Strategy

        21.3.13. Theranica Bio-Electronics Ltd.

            21.3.13.1. Overview

            21.3.13.2. Product Portfolio

            21.3.13.3. Key Financials

            21.3.13.4. Sales Footprint

            21.3.13.5. SWOT Analysis

            21.3.13.6. Strategy Overview

                21.3.13.6.1. Marketing Strategy

                21.3.13.6.2. Channel Strategy

        21.3.14. Propeller Health

            21.3.14.1. Overview

            21.3.14.2. Product Portfolio

            21.3.14.3. Key Financials

            21.3.14.4. Sales Footprint

            21.3.14.5. SWOT Analysis

            21.3.14.6. Strategy Overview

                21.3.14.6.1. Marketing Strategy

                21.3.14.6.2. Channel Strategy

        21.3.15. Orexo US, Inc.

            21.3.15.1. Overview

            21.3.15.2. Product Portfolio

            21.3.15.3. Key Financials

            21.3.15.4. Sales Footprint

            21.3.15.5. SWOT Analysis

            21.3.15.6. Strategy Overview

                21.3.15.6.1. Marketing Strategy

                21.3.15.6.2. Channel Strategy

        21.3.16. TALi Digital Limited

            21.3.16.1. Overview

            21.3.16.2. Product Portfolio

            21.3.16.3. Key Financials

            21.3.16.4. Sales Footprint

            21.3.16.5. SWOT Analysis

            21.3.16.6. Strategy Overview

                21.3.16.6.1. Marketing Strategy

                21.3.16.6.2. Channel Strategy

        21.3.17. Limbix Health, Inc. 

            21.3.17.1. Overview

            21.3.17.2. Product Portfolio

            21.3.17.3. Key Financials

            21.3.17.4. Sales Footprint

            21.3.17.5. SWOT Analysis

            21.3.17.6. Strategy Overview

                21.3.17.6.1. Marketing Strategy

                21.3.17.6.2. Channel Strategy

22. Assumptions and Acronyms Used

23. Research Methodology

Customize this Report

Let us know your requirement to get
100% FREE customization

List of Tables

Table 01: Global Digital Therapeutics Market Analysis 2017–2021 and Forecast 2022-2032

Table 02: Global Digital Therapeutics Market Analysis 2017–2021 and Forecast 2022-2032, by Solution

Table 03: Global Digital Therapeutics Market Analysis 2017–2021 and Forecast 2022-2032, by Application

Table 04: Global Digital Therapeutics Market Analysis 2017–2021 and Forecast 2022-2032, by Indication

Table 05: Global Digital Therapeutics Market Analysis 2017–2021 and Forecast 2022-2032, by Business Model

Table 06: Global Digital Therapeutics Market Application (US$ Bn) Analysis 2017–2021 and Forecast 2022-2032, by Region

Table 07: North America Digital Therapeutics Market Application (US$ Bn) Analysis 2017-2021 and Forecast 2022-2032, by Country

Table 08: North America Digital Therapeutics Market Analysis 2017–2021 and Forecast 2022-2032, by Solution

Table 09: North America Digital Therapeutics Market Analysis 2017–2021 and Forecast 2022-2032, by Solution

Table 10: North America Digital Therapeutics Market Application (US$ Bn) Analysis 2017-2021 and Forecast 2022-2032, by Application

Table 11: North America Digital Therapeutics Market Application (US$ Bn) Analysis 2017-2021 and Forecast 2022-2032, by Indication

Table 12: North America Digital Therapeutics Market Application (US$ Bn) Analysis 2017-2021 and Forecast 2022-2032, by Business Model

Table 13: Latin America Digital Therapeutics Market Application (US$ Bn) Analysis 2017-2021 and Forecast 2022-2032, by Country

Table 14: Latin America Digital Therapeutics Market Analysis 2017–2021 and Forecast 2022-2032, by Solution

Table 15: Latin America Digital Therapeutics Market Analysis 2017–2021 and Forecast 2022-2032, by Solution

Table 16: Latin America Digital Therapeutics Market Application (US$ Bn) Analysis 2017-2021 and Forecast 2022-2032, by Application

Table 17: Latin America Digital Therapeutics Market Application (US$ Bn) Analysis 2017-2021 and Forecast 2022-2032, by Indication

Table 18: Latin America Digital Therapeutics Market Application (US$ Bn) Analysis 2017-2021 and Forecast 2022-2032, by Business Model

Table 19: Europe Digital Therapeutics Market Application (US$ Bn) Analysis 2017-2021 and Forecast 2022-2032, by Country

Table 20: Europe Digital Therapeutics Market Analysis 2017–2021 and Forecast 2022-2032, by Solution

Table 21: Europe Digital Therapeutics Market Analysis 2017–2021 and Forecast 2022-2032, by Solution

Table 22: Europe Digital Therapeutics Market Application (US$ Bn) Analysis 2017-2021 and Forecast 2022-2032, by Application

Table 23: Europe Digital Therapeutics Market Application (US$ Bn) Analysis 2017-2021 and Forecast 2022-2032, by Indication

Table 24: Europe Digital Therapeutics Market Application (US$ Bn) Analysis 2017-2021 and Forecast 2022-2032, by Business Model

Table 25: South Asia Digital Therapeutics Market Application (US$ Bn) Analysis 2017-2021 and Forecast 2022-2032, by Country

Table 26: South Asia Digital Therapeutics Market Analysis 2017–2021 and Forecast 2022-2032, by Solution

Table 27: South Asia Digital Therapeutics Market Analysis 2017–2021 and Forecast 2022-2032, by Solution

Table 28: South Asia Digital Therapeutics Market Application (US$ Bn) Analysis 2017-2021 and Forecast 2022-2032, by Application

Table 29: South Asia Digital Therapeutics Market Application (US$ Bn) Analysis 2017-2021 and Forecast 2022-2032, by Indication

Table 30: South Asia Digital Therapeutics Market Application (US$ Bn) Analysis 2017-2021 and Forecast 2022-2032, by Business Model

Table 31: East Asia Digital Therapeutics Market Application (US$ Bn) Analysis 2017-2021 and Forecast 2022-2032, by Country

Table 32: East Asia Digital Therapeutics Market Analysis 2017–2021 and Forecast 2022-2032, by Solution

Table 33: East Asia Digital Therapeutics Market Analysis 2017–2021 and Forecast 2022-2032, by Solution

Table 34: East Asia Digital Therapeutics Market Application (US$ Bn) Analysis 2017-2021 and Forecast 2022-2032, by Application

Table 35: East Asia Digital Therapeutics Market Application (US$ Bn) Analysis 2017-2021 and Forecast 2022-2032, by Indication

Table 36: East Asia Digital Therapeutics Market Application (US$ Bn) Analysis 2017-2021 and Forecast 2022-2032, by Business Model

Table 37: Oceania Digital Therapeutics Market Application (US$ Bn) Analysis 2017-2021 and Forecast 2022-2032, by Country

Table 38: Oceania Digital Therapeutics Market Analysis 2017–2021 and Forecast 2022-2032, by Solution

Table 39: Oceania Digital Therapeutics Market Analysis 2017–2021 and Forecast 2022-2032, by Solution

Table 40: Oceania Digital Therapeutics Market Application (US$ Bn) Analysis 2017-2021 and Forecast 2022-2032, by Application

Table 41: Oceania Digital Therapeutics Market Application (US$ Bn) Analysis 2017-2021 and Forecast 2022-2032, by Indication

Table 42: Oceania Digital Therapeutics Market Application (US$ Bn) Analysis 2017-2021 and Forecast 2022-2032, by Business Model

Table 43: MEA Digital Therapeutics Market Application (US$ Bn) Analysis 2017-2021 and Forecast 2022-2032, by Country

Table 44: MEA Digital Therapeutics Market Analysis 2017–2021 and Forecast 2022-2032, by Solution

Table 45: MEA Digital Therapeutics Market Analysis 2017–2021 and Forecast 2022-2032, by Solution

Table 46: MEA Digital Therapeutics Market Application (US$ Bn) Analysis 2017-2021 and Forecast 2022-2032, by Application

Table 47: MEA Digital Therapeutics Market Application (US$ Bn) Analysis 2017-2021 and Forecast 2022-2032, by Indication

Table 48: MEA Digital Therapeutics Market Application (US$ Bn) Analysis 2017-2021 and Forecast 2022-2032, by Business Model

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst
List of Charts

Figure 01: Global Digital Therapeutics Market Value Share, by Solution 2022(E)

Figure 02: Global Digital Therapeutics Market Value Share, by Application 2022(E)

Figure 03: Global Digital Therapeutics Market Value Share, by Indication 2022(E)

Figure 04: Global Digital Therapeutics Market Value Share, by Business Model 2022(E)

Figure 05: Global Digital Therapeutics Market Value (US$ Mn) Analysis, 2017–2021

Figure 06: Global Digital Therapeutics Market Value (US$ Mn) Forecast, 2021–2032

Figure 07: Global Digital Therapeutics Market Absolute $ Opportunity, 2022 - 2032

Figure 08: Global Digital Therapeutics Market Value Share (%) Analysis 2022 & 2032, by Solution

Figure 09: Global Digital Therapeutics Market Y-o-Y Growth (%) Analysis 2022-2032, by Solution

Figure 10: Global Digital Therapeutics Market Attractiveness Analysis, by Solution

Figure 11: Global Digital Therapeutics Market Value Share (%) Analysis 2022 & 2032, by Application

Figure 12: Global Digital Therapeutics Market Y-o-Y Growth (%) Analysis 2022-2032, by Application

Figure 13: Global Digital Therapeutics Market Attractiveness Analysis, by Application

Figure 14: Global Digital Therapeutics Market Value Share (%) Analysis 2022 & 2032, by Indication

Figure 15: Global Digital Therapeutics Market Y-o-Y Growth (%) Analysis 2022-2032, by Indication

Figure 16: Global Digital Therapeutics Market Attractiveness Analysis, by Indication

Figure 17: Global Digital Therapeutics Market Value Share (%) Analysis 2022 & 2032, by Business Model

Figure 18: Global Digital Therapeutics Market Y-o-Y Growth (%) Analysis 2022-2032, by Business Model

Figure 19: Global Digital Therapeutics Market Attractiveness Analysis, by Business Model

Figure 20: Global Digital Therapeutics Market Share, by Region, 2022 & 2032

Figure 21: Global Digital Therapeutics Market Attractiveness Analysis by Region, 2022-2032

Figure 22: Global Digital Therapeutics Market Attractiveness Analysis by Region, 2021-2031

Figure 23: North America Digital Therapeutics Market Share, by Country (2022)

Figure 24: North America Digital Therapeutics Market Share, by Solution (2022)

Figure 25: North America Digital Therapeutics Market Share, by Application (2022)

Figure 26: North America Digital Therapeutics Market Share, by Indication (2022)

Figure 27: North America Digital Therapeutics Market Share, by Business Model (2022)

Figure 28: North America Digital Therapeutics Market Application (US$ Mn) Analysis, 2017-2021

Figure 29: North America Digital Therapeutics Market Application (US$ Mn) & Y-o-Y Growth (%) Analysis, 2022-2032

Figure 30: North America Digital Therapeutics Market Attractiveness Analysis, by Country

Figure 31: North America Digital Therapeutics Market Attractiveness Analysis, by Solution

Figure 32: North America Digital Therapeutics Market Attractiveness Analysis, by Application

Figure 33: North America Digital Therapeutics Market Attractiveness Analysis, by Indication

Figure 34: North America Digital Therapeutics Market Attractiveness Analysis, by Business Model

Figure 35: Latin America Digital Therapeutics Market Share, by Country (2022)

Figure 36: Latin America Digital Therapeutics Market Share, by Solution (2022)

Figure 37: Latin America Digital Therapeutics Market Share, by Application (2022)

Figure 38: Latin America Digital Therapeutics Market Share, by Indication (2022)

Figure 39: Latin America Digital Therapeutics Market Share, by Business Model (2022)

Figure 40: Latin America Digital Therapeutics Market Application (US$ Mn) Analysis, 2017-2021

Figure 41: Latin America Digital Therapeutics Market Application (US$ Mn) & Y-o-Y Growth (%) Analysis, 2022-2032

Figure 42: Latin America Digital Therapeutics Market Attractiveness Analysis, by Country

Figure 43: Latin America Digital Therapeutics Market Attractiveness Analysis, by Solution

Figure 44: Latin America Digital Therapeutics Market Attractiveness Analysis, by Application

Figure 45: Latin America Digital Therapeutics Market Attractiveness Analysis, by Indication

Figure 46: Latin America Digital Therapeutics Market Attractiveness Analysis, by Business Model

Figure 47: Europe Digital Therapeutics Market Share, by Country (2022)

Figure 48: Europe Digital Therapeutics Market Share, by Solution (2022)

Figure 49: Europe Digital Therapeutics Market Share, by Application (2022)

Figure 50: Europe Digital Therapeutics Market Share, by Indication (2022)

Figure 51: Europe Digital Therapeutics Market Share, by Business Model (2022)

Figure 52: Europe Digital Therapeutics Market Application (US$ Mn) Analysis, 2017-2021

Figure 53: Europe Digital Therapeutics Market Application (US$ Mn) & Y-o-Y Growth (%) Analysis, 2022-2032

Figure 54: Europe Digital Therapeutics Market Attractiveness Analysis, by Country

Figure 55: Europe Digital Therapeutics Market Attractiveness Analysis, by Solution

Figure 56: Europe Digital Therapeutics Market Attractiveness Analysis, by Application

Figure 57: Europe Digital Therapeutics Market Attractiveness Analysis, by Indication

Figure 58: Europe Digital Therapeutics Market Attractiveness Analysis, by Business Model

Figure 59: South Asia Digital Therapeutics Market Share, by Country (2022)

Figure 60: South Asia Digital Therapeutics Market Share, by Solution (2022)

Figure 61: South Asia Digital Therapeutics Market Share, by Application (2022)

Figure 62: South Asia Digital Therapeutics Market Share, by Indication (2022)

Figure 63: South Asia Digital Therapeutics Market Share, by Business Model (2022)

Figure 64: South Asia Digital Therapeutics Market Application (US$ Mn) Analysis, 2017-2021

Figure 65: South Asia Digital Therapeutics Market Application (US$ Mn) & Y-o-Y Growth (%) Analysis, 2022-2032

Figure 66: South Asia Digital Therapeutics Market Attractiveness Analysis, by Country

Figure 67: South Asia Digital Therapeutics Market Attractiveness Analysis, by Solution

Figure 68: South Asia Digital Therapeutics Market Attractiveness Analysis, by Application

Figure 69: South Asia Digital Therapeutics Market Attractiveness Analysis, by Indication

Figure 70: South Asia Digital Therapeutics Market Attractiveness Analysis, by Business Model

Figure 71: East Asia Digital Therapeutics Market Share, by Country (2022)

Figure 72: East Asia Digital Therapeutics Market Share, by Solution (2022)

Figure 73: East Asia Digital Therapeutics Market Share, by Application (2022)

Figure 74: East Asia Digital Therapeutics Market Share, by Indication (2022)

Figure 75: East Asia Digital Therapeutics Market Share, by Business Model (2022)

Figure 76: East Asia Digital Therapeutics Market Application (US$ Mn) Analysis, 2017-2021

Figure 77: East Asia Digital Therapeutics Market Application (US$ Mn) & Y-o-Y Growth (%) Analysis, 2022-2032

Figure 78: East Asia Digital Therapeutics Market Attractiveness Analysis, by Country

Figure 79: East Asia Digital Therapeutics Market Attractiveness Analysis, by Solution

Figure 80: East Asia Digital Therapeutics Market Attractiveness Analysis, by Application

Figure 81: East Asia Digital Therapeutics Market Attractiveness Analysis, by Indication

Figure 82: East Asia Digital Therapeutics Market Attractiveness Analysis, by Business Model

Figure 83: Oceania Digital Therapeutics Market Share, by Country (2022)

Figure 84: Oceania Digital Therapeutics Market Share, by Solution (2022)

Figure 85: Oceania Digital Therapeutics Market Share, by Application (2022)

Figure 86: Oceania Digital Therapeutics Market Share, by Indication (2022)

Figure 87: Oceania Digital Therapeutics Market Share, by Business Model (2022)

Figure 88: Oceania Digital Therapeutics Market Application (US$ Mn) Analysis, 2017-2021

Figure 89: Oceania Digital Therapeutics Market Application (US$ Mn) & Y-o-Y Growth (%) Analysis, 2022-2032

Figure 90: Oceania Digital Therapeutics Market Attractiveness Analysis, by Country

Figure 91: Oceania Digital Therapeutics Market Attractiveness Analysis, by Solution

Figure 92: Oceania Digital Therapeutics Market Attractiveness Analysis, by Application

Figure 93: Oceania Digital Therapeutics Market Attractiveness Analysis, by Indication

Figure 94: Oceania Digital Therapeutics Market Attractiveness Analysis, by Business Model

Figure 95: MEA Digital Therapeutics Market Share, by Country (2022)

Figure 96: MEA Digital Therapeutics Market Share, by Solution (2022)

Figure 97: MEA Digital Therapeutics Market Share, by Application (2022)

Figure 98: MEA Digital Therapeutics Market Share, by Indication (2022)

Figure 99: MEA Digital Therapeutics Market Share, by Business Model (2022)

Figure 100: MEA Digital Therapeutics Market Application (US$ Mn) Analysis, 2017-2021

Figure 101: MEA Digital Therapeutics Market Application (US$ Mn) & Y-o-Y Growth (%) Analysis, 2022-2032

Figure 102: MEA Digital Therapeutics Market Attractiveness Analysis, by Country

Figure 103: MEA Digital Therapeutics Market Attractiveness Analysis, by Solution

Figure 104: MEA Digital Therapeutics Market Attractiveness Analysis, by Application

Figure 105: MEA Digital Therapeutics Market Attractiveness Analysis, by Indication

Figure 106: MEA Digital Therapeutics Market Attractiveness Analysis, by Business Model

Figure 107: Global Digital Therapeutics Market Value Proportion Analysis, by Countries, 2022

Figure 108: Global Digital Therapeutics Market, Global Vs. Country Growth Y-o-Y (%) Comparison, 2022-2032

Figure 109: U.S. Market Value Proportion Analysis, 2022

Figure 110: Global Vs. U.S. Growth Comparison

Figure 111: U.S. Digital Therapeutics Market Share Analysis (%) by Solution, 2022 & 2032

Figure 112: U.S. Digital Therapeutics Market Share Analysis (%) by Application, 2022 & 2032

Figure 113: U.S. Digital Therapeutics Market Share Analysis (%) by Indication, 2022 & 2032

Figure 114: U.S. Digital Therapeutics Market Share Analysis (%) by Business Model, 2022 & 2032

Figure 115: Canada Market Value Proportion Analysis, 2022

Figure 116: Global Vs. Canada Growth Comparison

Figure 117: Canada Digital Therapeutics Market Share Analysis (%) by Solution, 2022 & 2032

Figure 118: Canada Digital Therapeutics Market Share Analysis (%) by Application, 2022 & 2032

Figure 119: Canada Digital Therapeutics Market Share Analysis (%) by Indication, 2022 & 2032

Figure 120: Canada Digital Therapeutics Market Share Analysis (%) by Business Model, 2022 & 2032

Figure 121: Brazil Market Value Proportion Analysis, 2022

Figure 122: Global Vs. Brazil Growth Comparison

Figure 123: Brazil Digital Therapeutics Market Share Analysis (%) by Solution, 2022 & 2032

Figure 124: Brazil Digital Therapeutics Market Share Analysis (%) by Application, 2022 & 2032

Figure 125: Brazil Digital Therapeutics Market Share Analysis (%) by Indication, 2022 & 2032

Figure 126: Brazil Digital Therapeutics Market Share Analysis (%) by Business Model, 2022 & 2032

Figure 127: Mexico Market Value Proportion Analysis, 2022

Figure 128: Global Vs. Mexico Growth Comparison

Figure 129: Mexico Digital Therapeutics Market Share Analysis (%) by Solution, 2022 & 2032

Figure 130: Mexico Digital Therapeutics Market Share Analysis (%) by Application, 2022 & 2032

Figure 131: Mexico Digital Therapeutics Market Share Analysis (%) by Indication, 2022 & 2032

Figure 132: Mexico Digital Therapeutics Market Share Analysis (%) by Business Model, 2022 & 2032

Figure 133: Germany Market Value Proportion Analysis, 2022

Figure 134: Global Vs. Germany Growth Comparison

Figure 135: Germany Digital Therapeutics Market Share Analysis (%) by Solution, 2022 & 2032

Figure 136: Germany Digital Therapeutics Market Share Analysis (%) by Application, 2022 & 2032

Figure 137: Germany Digital Therapeutics Market Share Analysis (%) by Indication, 2022 & 2032

Figure 138: Germany Digital Therapeutics Market Share Analysis (%) by Business Model, 2022 & 2032

Figure 139: Italy Market Value Proportion Analysis, 2022

Figure 140: Global Vs. Italy Growth Comparison

Figure 141: Italy Digital Therapeutics Market Share Analysis (%) by Solution, 2022 & 2032

Figure 142: Italy Digital Therapeutics Market Share Analysis (%) by Application, 2022 & 2032

Figure 143: Italy Digital Therapeutics Market Share Analysis (%) by Indication, 2022 & 2032

Figure 144: Italy Digital Therapeutics Market Share Analysis (%) by Business Model, 2022 & 2032

Figure 145: France Market Value Proportion Analysis, 2022

Figure 146: Global Vs. France Growth Comparison

Figure 147: France Digital Therapeutics Market Share Analysis (%) by Solution, 2022 & 2032

Figure 148: France Digital Therapeutics Market Share Analysis (%) by Application, 2022 & 2032

Figure 149: France Digital Therapeutics Market Share Analysis (%) by Indication, 2022 & 2032

Figure 150: France Digital Therapeutics Market Share Analysis (%) by Business Model, 2022 & 2032

Figure 151: U.K Market Value Proportion Analysis, 2022

Figure 152: Global Vs. U.K Growth Comparison

Figure 153: U.K Digital Therapeutics Market Share Analysis (%) by Solution, 2022 & 2032

Figure 154: U.K Digital Therapeutics Market Share Analysis (%) by Application, 2022 & 2032

Figure 155: U.K Digital Therapeutics Market Share Analysis (%) by Indication, 2022 & 2032

Figure 156: U.K Digital Therapeutics Market Share Analysis (%) by Business Model, 2022 & 2032

Figure 157: Spain Market Value Proportion Analysis, 2022

Figure 158: Global Vs. Spain Growth Comparison

Figure 159: Spain Digital Therapeutics Market Share Analysis (%) by Solution, 2022 & 2032

Figure 160: Spain Digital Therapeutics Market Share Analysis (%) by Application, 2022 & 2032

Figure 161: Spain Digital Therapeutics Market Share Analysis (%) by Indication, 2022 & 2032

Figure 162: Spain Digital Therapeutics Market Share Analysis (%) by Business Model, 2022 & 2032

Figure 163: BENELUX Market Value Proportion Analysis, 2022

Figure 164: Global Vs. BENELUX Growth Comparison

Figure 165: BENELUX Digital Therapeutics Market Share Analysis (%) by Solution, 2022 & 2032

Figure 166: BENELUX Digital Therapeutics Market Share Analysis (%) by Application, 2022 & 2032

Figure 167: BENELUX Digital Therapeutics Market Share Analysis (%) by Indication, 2022 & 2032

Figure 168: BENELUX Digital Therapeutics Market Share Analysis (%) by Business Model, 2022 & 2032

Figure 169: Russia Market Value Proportion Analysis, 2022

Figure 170: Global Vs. Russia Growth Comparison

Figure 171: Russia Digital Therapeutics Market Share Analysis (%) by Solution, 2022 & 2032

Figure 172: Russia Digital Therapeutics Market Share Analysis (%) by Application, 2022 & 2032

Figure 173: Russia Digital Therapeutics Market Share Analysis (%) by Indication, 2022 & 2032

Figure 174: Russia Digital Therapeutics Market Share Analysis (%) by Business Model, 2022 & 2032

Figure 175: India Market Value Proportion Analysis, 2022

Figure 176: Global Vs. India Growth Comparison

Figure 177: India Digital Therapeutics Market Share Analysis (%) by Solution, 2022 & 2032

Figure 178: India Digital Therapeutics Market Share Analysis (%) by Application, 2022 & 2032

Figure 179: India Digital Therapeutics Market Share Analysis (%) by Indication, 2022 & 2032

Figure 180: India Digital Therapeutics Market Share Analysis (%) by Business Model, 2022 & 2032

Figure 181: Thailand Market Value Proportion Analysis, 2022

Figure 182: Global Vs. Thailand Growth Comparison

Figure 183: Thailand Digital Therapeutics Market Share Analysis (%) by Solution, 2022 & 2032

Figure 184: Thailand Digital Therapeutics Market Share Analysis (%) by Application, 2022 & 2032

Figure 185: Thailand Digital Therapeutics Market Share Analysis (%) by Indication, 2022 & 2032

Figure 186: Thailand Digital Therapeutics Market Share Analysis (%) by Business Model, 2022 & 2032

Figure 187: Malaysia Market Value Proportion Analysis, 2022

Figure 188: Global Vs. Malaysia Growth Comparison

Figure 189: Malaysia Digital Therapeutics Market Share Analysis (%) by Solution, 2022 & 2032

Figure 190: Malaysia Digital Therapeutics Market Share Analysis (%) by Application, 2022 & 2032

Figure 191: Malaysia Digital Therapeutics Market Share Analysis (%) by Indication, 2022 & 2032

Figure 192: Malaysia Digital Therapeutics Market Share Analysis (%) by Business Model, 2022 & 2032

Figure 193: Indonesia Market Value Proportion Analysis, 2022

Figure 194: Global Vs. Indonesia Growth Comparison

Figure 195: Indonesia Digital Therapeutics Market Share Analysis (%) by Solution, 2022 & 2032

Figure 196: Indonesia Digital Therapeutics Market Share Analysis (%) by Application, 2022 & 2032

Figure 197: Indonesia Digital Therapeutics Market Share Analysis (%) by Indication, 2022 & 2032

Figure 198: Indonesia Digital Therapeutics Market Share Analysis (%) by Business Model, 2022 & 2032

Figure 199: China Market Value Proportion Analysis, 2022

Figure 200: Global Vs. China Growth Comparison

Figure 201: China Digital Therapeutics Market Share Analysis (%) by Solution, 2022 & 2032

Figure 202: China Digital Therapeutics Market Share Analysis (%) by Application, 2022 & 2032

Figure 203: China Digital Therapeutics Market Share Analysis (%) by Indication, 2022 & 2032

Figure 204: China Digital Therapeutics Market Share Analysis (%) by Business Model, 2022 & 2032

Figure 205: Japan Market Value Proportion Analysis, 2022

Figure 206: Global Vs. Japan Growth Comparison

Figure 207: Japan Digital Therapeutics Market Share Analysis (%) by Solution, 2022 & 2032

Figure 208: Japan Digital Therapeutics Market Share Analysis (%) by Application, 2022 & 2032

Figure 209: Japan Digital Therapeutics Market Share Analysis (%) by Indication, 2022 & 2032

Figure 210: Japan Digital Therapeutics Market Share Analysis (%) by Business Model, 2022 & 2032

Figure 211: South Korea Market Value Proportion Analysis, 2022

Figure 212: Global Vs. South Korea Growth Comparison

Figure 213: South Korea Digital Therapeutics Market Share Analysis (%) by Solution, 2022 & 2032

Figure 214: South Korea Digital Therapeutics Market Share Analysis (%) by Application, 2022 & 2032

Figure 215: South Korea Digital Therapeutics Market Share Analysis (%) by Indication, 2022 & 2032

Figure 216: South Korea Digital Therapeutics Market Share Analysis (%) by Business Model, 2022 & 2032

Figure 217: Australia Market Value Proportion Analysis, 2022

Figure 218: Global Vs. Australia Growth Comparison

Figure 219: Australia Digital Therapeutics Market Share Analysis (%) by Solution, 2022 & 2032

Figure 220: Australia Digital Therapeutics Market Share Analysis (%) by Application, 2022 & 2032

Figure 221: Australia Digital Therapeutics Market Share Analysis (%) by Indication, 2022 & 2032

Figure 222: Australia Digital Therapeutics Market Share Analysis (%) by Business Model, 2022 & 2032

Figure 223: New Zealand Market Value Proportion Analysis, 2022

Figure 224: Global Vs. New Zealand Growth Comparison

Figure 225: New Zealand Digital Therapeutics Market Share Analysis (%) by Solution, 2022 & 2032

Figure 226: New Zealand Digital Therapeutics Market Share Analysis (%) by Application, 2022 & 2032

Figure 227: New Zealand Digital Therapeutics Market Share Analysis (%) by Indication, 2022 & 2032

Figure 228: New Zealand Digital Therapeutics Market Share Analysis (%) by Business Model, 2022 & 2032

Figure 229: GCC Countries Market Value Proportion Analysis, 2022

Figure 230: Global Vs. GCC Countries Growth Comparison

Figure 231: GCC Countries Digital Therapeutics Market Share Analysis (%) by Solution, 2022 & 2032

Figure 232: GCC Countries Digital Therapeutics Market Share Analysis (%) by Application, 2022 & 2032

Figure 233: GCC Countries Digital Therapeutics Market Share Analysis (%) by Indication, 2022 & 2032

Figure 234: GCC Countries Digital Therapeutics Market Share Analysis (%) by Business Model, 2022 & 2032

Figure 235: Turkey Market Value Proportion Analysis, 2022

Figure 236: Global Vs. Turkey Growth Comparison

Figure 237: Turkey Digital Therapeutics Market Share Analysis (%) by Solution, 2022 & 2032

Figure 238: Turkey Digital Therapeutics Market Share Analysis (%) by Application, 2022 & 2032

Figure 239: Turkey Digital Therapeutics Market Share Analysis (%) by Indication, 2022 & 2032

Figure 240: Turkey Digital Therapeutics Market Share Analysis (%) by Business Model, 2022 & 2032

Figure 241: Israel Market Value Proportion Analysis, 2022

Figure 242: Global Vs. Israel Growth Comparison

Figure 243: Israel Digital Therapeutics Market Share Analysis (%) by Solution, 2022 & 2032

Figure 244: Israel Digital Therapeutics Market Share Analysis (%) by Application, 2022 & 2032

Figure 245: Israel Digital Therapeutics Market Share Analysis (%) by Indication, 2022 & 2032

Figure 246: Israel Digital Therapeutics Market Share Analysis (%) by Business Model, 2022 & 2032

Figure 247: South Africa Market Value Proportion Analysis, 2022

Figure 248: Global Vs. South Africa Growth Comparison

Figure 249: South Africa Digital Therapeutics Market Share Analysis (%) by Solution, 2022 & 2032

Figure 250: South Africa Digital Therapeutics Market Share Analysis (%) by Application, 2022 & 2032

Figure 251: South Africa Digital Therapeutics Market Share Analysis (%) by Indication, 2022 & 2032

Figure 252: South Africa Digital Therapeutics Market Share Analysis (%) by Business Model, 2022 & 2032

Need specific information?

Request Customization

Explore Healthcare Insights

View Reports

Recommendations

Healthcare

Neurology Digital Therapeutics Market

Published : December 2021

Healthcare

Peptide Therapeutics Market

Published : February 2022

Healthcare

Lung Cancer Therapeutics Market

Published : February 2022

Healthcare

Leukemia Therapeutics Treatment Market

Published : February 2022

Google translate

Digital Therapeutics Market